Name: Ventricular Assist Devices - Current Advances and Applications in Heart Failure (en Inglés)
Price: 157100.00 CLP
Availability: InStock
Author: Purevjav, Enkhsaikhan ; Martinez, Hugo ; Towbin, Jeffrey
ISBN: 9781803564524

portada Ventricular Assist Devices - Current Advances and Applications in Heart Failure (en Inglés)

Formato

Libro Físico

Editorial

Intechopen

Autor

Purevjav, Enkhsaikhan ; Martinez, Hugo ; Towbin, Jeffrey

Idioma

Inglés

N° páginas

182

Encuadernación

Tapa Dura

Dimensiones

25.4 x 17.8 x 1.6 cm

Peso

0.65 kg.

ISBN13

9781803564524

Categorías

Enfermedades cardiovasculares

Ventricular Assist Devices - Current Advances and Applications in Heart Failure (en Inglés)

Purevjav, Enkhsaikhan ; Martinez, Hugo ; Towbin, Jeffrey (Autor) · Intechopen · Tapa Dura

Libro Nuevo

$ 157.100

$ 285.630

Ahorras: $ 128.530

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 01 de Agosto y el Martes 13 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Ventricular Assist Devices - Current Advances and Applications in Heart Failure (en Inglés)"

The heart pumps blood throughout our bodies and provides the oxygen and nutrients essential for life. There is a growing pandemic of heart failure despite advances in current diagnostics and treatments and improvements in heart transplantation. Improvements in mechanical circulatory support (MCS) devices have resulted in an exceptional increase in post-implantation survival rates in patients with advanced heart failure. Ventricular assist devices (VADs) can be implanted in patients with heart failure as a bridge to recovery that will help the failing heart to recover and pump blood effectively on its own, as a bridge to a heart transplant, or as a destination therapy with permanently implanted MCS devices. This book covers the history and recent advances and applications of VADs, important aspects of the management of risks and complications of circulatory support therapies, and myocardial remodeling that occurs during ventricular unloading.